Key statistics


The NIHR Clinical Research Network (CRN) makes it possible for patients and health professionals across England to participate in relevant clinical research studies within the NHS.

It works with patients and the public to make sure their needs are placed at the heart of all research and provides the opportunity for patients to gain earlier access to treatments through their participation. The CRN supports NHS research infrastructure, which underpins delivery of studies funded by charities, research funders and the life-sciences industry.

NHS ENGAGEMENT IN RESEARCH
100 per cent of NHS trusts supported opportunities for people to actively participate in clinical research, with 42 per cent of General Medical Practices now clinical research active.

OVER 600,000 PEOPLE INVOLVED IN RESEARCH
More than 605,000 people participated in clinical research studies. Including nearly 35,000 participants were recruited to commercial contract research studies last year.

INCREASED OPPORTUNITIES TO PARTICIPATE IN DEMENTIA RESEARCH
The Network continues to support the Government’s 2020 Dementia Challenge. Nearly 35,000 people were supported to participate in clinical research associated with dementias and neurodegeneration – a 62 per cent increase from 2014/15.

An increasing proportion of these people were recruited through Join Dementia Research, an online service which delivers opportunities for people to play their part in beating dementia; connecting researchers with people who want to participate in studies.

IMPROVED STUDY SET-UP AND DELIVERY
The Network supports studies to set up more rapidly, with 79 per cent of studies receiving NHS permission within 40 calendar days at all sites. The Network continues to demonstrate that the UK is internationally competitive in speed of study set-up.

The Network has a continued priority to improve delivery to time and recruitment target for all studies which it supports. We have increased the proportion of commercial contract studies and maintained the proportion of non-commercial studies delivered to time and recruitment target.

Reliable delivery is essential and the percentage of non-recruiting sites is now 12.7 per cent for commercial contract research – this is globally competitive. This competitiveness is also reflected in the recruitment of global and European first patients into multiple studies.

INCREASED INVESTMENT IN NHS CLINICAL RESEARCH
The number of new studies supported by the Network continues to grow, with the most significant increase in new studies sponsored by the life sciences industry. Last year the Network supported 1,787 new studies. Of those, 650 were new commercial contract studies – a figure that has continued to grow for the last five years.